Ten genes previously showing different evidence of association with multiple sclerosis have been selected to validate.
Methods:
Eleven polymorphisms were genotyped with the iPLEX™ Sequenom in a well-powered collection of Spanish origin including 2863 multiple sclerosis cases and 2930 controls.
Results:
Replication extended to the following polymorphisms: PKN2 (rs305217), GTF2B (rs7538427), EPHA4 (rs1517440), YTHDF3 (rs12115114), ANKFN1 (rs17758761) and PTPRM (rs4798571), which did not reach the threshold of significance in a follow-up of the first genome-wide association study (GWAS) conducted in multiple sclerosis; TMEM39A (rs1132200), which appeared as a newly identified susceptibility gene in the same study; a gene previously reaching GWAS significance in Italy, CBLB (rs9657904); IL12B (rs6887695, rs10045431), a susceptibility gene shared by diverse autoimmune diseases and, finally, another gene showing inconclusive association with multiple sclerosis, CNR1 (rs1049353).
Conclusions:
Pooled analysis corroborated the effect on MS predisposition of three genes: TMEM39A [rs1132200: pM-H=0.001; ORM-H (95% CI)= 0.84 (0.75–0.93)], IL12B [rs6887695: pM-H=0.03; ORM-H (95% CI)= 1.09 (1.01–1.17)] and CBLB [rs9657904: pM-H=0.01; ORM-H (95% CI)= 0.89 (0.81–0.97)].
HandelAEHandunnetthiLGiovannoniGEbersGCRamagopalanSV. Genetic and environmental factors and the distribution of multiple sclerosis in Europe. Eur J Neurol. 2010; 17: 1210–4.
2.
JersildCAmmitzbollTClausenJFogT. Association between HL-A antigens and measles antibody in multiple sclerosis. Lancet. 1973; 1: 151–2.
3.
Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene). Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet. 2009; 41: 824–8.
4.
ComabellaMCraigDWCamina-TatoM. Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500,000 single nucleotide polymorphisms. PLoS One. 2008; 3: e3490.
5.
International Multiple Sclerosis Genetics Consortium, IMSGC. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med. 2007; 357: 851–62.
6.
JakkulaELeppaVSulonenAM. Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene. Am J Hum Genet. 2010; 86: 285–91.
7.
SannaSPitzalisMZoledziewskaM. Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis. Nat Genet. 2010; 42: 495–7.
8.
International Multiple Sclerosis Genetics Consortium, IMSGC. Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci. Hum Mol Genet. 2010; 19: 953–62.
9.
CorradoLBergamaschiLBarizzoneN. Association of the CBLB gene with multiple sclerosis: new evidence from a replication study in an Italian population. J Med Genet. 2011; 48: 210–1.
10.
TsunemiYSaekiHNakamuraK. Interleukin-12 p40 gene (IL12B) 3’-untranslated region polymorphism is associated with susceptibility to atopic dermatitis and psoriasis vulgaris. J Dermatol Sci. 2002; 30: 161–6.
11.
CargillMSchrodiSJChangM. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet. 2007; 80: 273–90.
12.
WuYLuZChenYXueFChenXZhengJ. Replication of association between interleukin-23 receptor (IL-23R) and its ligand (IL-12B) polymorphisms and psoriasis in the Chinese Han population. Hum Immunol. 2010; 71: 1255–8.
13.
FisherSATremellingMAndersonCA. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn’s disease. Nat Genet. 2008; 40: 710–2.
14.
DanoyPPryceKHadlerJ. Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn’s disease. PLoS Genet. 2010; 6: e1001195.
15.
RamilESanchezAJGonzalez-PerezP. The cannabinoid receptor 1 gene (CNR1) and multiple sclerosis: an association study in two case-control groups from Spain. Mult Scler. 2010; 16: 139–46.
16.
PoserCMPatyDWScheinbergL. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983; 13: 227–31.
17.
CavanillasMLFernandezOComabellaM. Replication of top markers of a genome-wide association study in multiple sclerosis in Spain. Genes Immun. 2011; 12: 110–5.
18.
ManolioTACollinsFSCoxNJ. Finding the missing heritability of complex diseases. Nature. 2009; 461: 747–53.
19.
AulchenkoYSHoppenbrouwersIARamagopalanSV. Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis. Nat Genet. 2008; 40: 1402–3.
20.
BoothDRHeardRNStewartGJ. Lack of support for association between the KIF1B rs10492972[C] variant and multiple sclerosis. Nat Genet. 2010; 42: 469-70; author reply 70–1.
21.
BergholdtRTaxvigCEisingSNerupJPociotF. CBLB variants in type 1 diabetes and their genetic interaction with CTLA4. J Leukoc Biol. 2005; 77: 579–85.
22.
PayneFCooperJDWalkerNM. Interaction analysis of the CBLB and CTLA4 genes in type 1 diabetes. J Leukoc Biol. 2007; 81: 581–3.
23.
FilerCHoPSmithRL. Investigation of association of the IL12B and IL23R genes with psoriatic arthritis. Arthritis Rheum. 2008; 58: 3705–9.
24.
MarquezAMendozaJLTaxoneraC. IL23R and IL12B polymorphisms in Spanish IBD patients: no evidence of interaction. Inflamm Bowel Dis. 2008; 14: 1192–6.
25.
AndersonCABoucherGLeesCW. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet. 2011; 43: 246–52.
26.
GatevaVSandlingJKHomG. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet. 2009; 41: 1228–33.
27.
CaponFDi MeglioPSzaubJ. Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis. Hum Genet. 2007; 122: 201–6.
28.
BegovichABChangMCaillierSJ. The autoimmune disease-associated IL12B and IL23R polymorphisms in multiple sclerosis. Hum Immunol. 2007; 68: 934–7.
29.
AllozaIHeggartySGorisA. Interleukin-12 p40 polymorphism and susceptibility to multiple sclerosis. Ann Neurol. 2002; 52: 524–5.
30.
van VeenTCrusiusJBSchrijverHM. Interleukin-12p40 genotype plays a role in the susceptibility to multiple sclerosis. Ann Neurol. 2001; 50: 275.
31.
WalshJPBerryJLiuS. The clinical presentation of autoimmune thyroid disease in men is associated with IL12B genotype. Clin Endocrinol (Oxf). 2011; 74: 508–12.
32.
International Multiple Sclerosis Genetics Consortium, IMSGC. IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci. Genes Immun. 2010; 11: 397–405.
33.
RossiSButtariFStuderV. The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis. Mult Scler. 2011; 17: 281–8.
34.
StorrMEmmerdingerDDiegelmannJ. The cannabinoid 1 receptor (CNR1) 1359 G/A polymorphism modulates susceptibility to ulcerative colitis and the phenotype in Crohn’s disease. PLoS One. 2010; 5: e9453.
35.
MkhikianHGrigorianALiCF. Genetics and the environment converge to dysregulate N-glycosylation in multiple sclerosis. Nat Commun. 2011; 2: 334.
36.
International Multiple Sclerosis Genetics Consortium; Wellcome Trust Case Control Consortium 2. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 2011Aug10; 476(7359): 214–9.
